sellWeak cluster of 410b5-1 plan
HUSSAIN IQBAL J sold $99k of CNTA
General Counsel at Centessa Pharmaceuticals plc. 6,000 shares at an average of $16.45, traded Mar 17, 2025, filed Mar 19, 2025.
Warning score
5Value
$99k
6,000 shares
Holdings after
105,386
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-25-000040, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 17, 2025 | MOption exercise Ordinary Shares10b5-1 | +6,000 | $5.84 | $35k | 111,386 | Mar 19, 2025 |
| Mar 17, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -6,000 | $16.45 | $99k | 105,386 | Mar 19, 2025 |
| Mar 17, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 309,559 | Mar 19, 2025 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 6Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | Weinhoff Gregory M Chief Business Officer | $163k | 10,000 | |
| 49Moderate | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | SAHA SAURABH Chief Executive Officer | $918k | 55,000 | |
| 5Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | CHAO DAVID M Chief Administrative Officer | $120k | 7,000 | |
| 22Weak | sell 310b5-1 | CNTA Centessa Pharmaceuticals plc | Weinhoff Gregory M Chief Business Officer | $175k | 11,494 | |
| 48Moderate | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | SAHA SAURABH Chief Executive Officer | $876k | 55,000 | |
| 5Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | HUSSAIN IQBAL J General Counsel | $97k | 6,000 | |
| 24Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | Anderson Karen M. Chief People Officer | $589k | 30,955 | |
| 25Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | Anderson Karen M. Chief People Officer | $109k | 6,471 | |
| 22Weak | sell 410b5-1 | CNTA Centessa Pharmaceuticals plc | Bush Tia L Chief Technology & Quality Ofc | $185k | 11,000 | |
| 22Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | Weinhoff Gregory M Chief Business Officer | $193k | 11,742 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.